Concomitantly, TGR5 agonists, antagonizing FXR can stimulate adipose tissue thermogenesis, boost energy metabolism, and reduce inflammation.154 Moreover, they have been reported to alleviate obesity and MS in mouse models.155. This evidence concerns the gene NR1H4 and obesity disorder.